Organovo Holdings Company Profile (NASDAQ:ONVO)

About Organovo Holdings (NASDAQ:ONVO)

Organovo Holdings logoOrganovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ONVO
  • CUSIP: N/A
  • Web:
  • Market Cap: $157.06 million
  • Outstanding Shares: 106,123,000
Average Prices:
  • 50 Day Moving Avg: $2.04
  • 200 Day Moving Avg: $2.47
  • 52 Week Range: $1.32 - $4.08
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.47
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $4.33 million
  • Price / Sales: 37.25
  • Book Value: $0.54 per share
  • Price / Book: 2.81
  • EBITDA: ($38,770,000.00)
  • Net Margins: -918.97%
  • Return on Equity: -65.49%
  • Return on Assets: -60.15%
  • Current Ratio: 15.72%
  • Quick Ratio: 15.60%
  • Average Volume: 1.05 million shs.
  • Beta: 3.02
  • Short Ratio: 21.68

Frequently Asked Questions for Organovo Holdings (NASDAQ:ONVO)

What is Organovo Holdings' stock symbol?

Organovo Holdings trades on the NASDAQ under the ticker symbol "ONVO."

How were Organovo Holdings' earnings last quarter?

Organovo Holdings, Inc. (NASDAQ:ONVO) released its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.10). The firm had revenue of $0.99 million for the quarter, compared to analyst estimates of $0.92 million. Organovo Holdings had a negative return on equity of 65.49% and a negative net margin of 918.97%. The business's quarterly revenue was up 11.1% compared to the same quarter last year. View Organovo Holdings' Earnings History.

When will Organovo Holdings make its next earnings announcement?

Organovo Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Organovo Holdings.

Where is Organovo Holdings' stock going? Where will Organovo Holdings' stock price be in 2017?

4 brokers have issued 1-year price objectives for Organovo Holdings' shares. Their forecasts range from $3.75 to $15.00. On average, they expect Organovo Holdings' share price to reach $6.94 in the next twelve months. View Analyst Ratings for Organovo Holdings.

Who are some of Organovo Holdings' key competitors?

Who are Organovo Holdings' key executives?

Organovo Holdings' management team includes the folowing people:

  • Taylor J. Crouch, President, Chief Executive Officer
  • Eric Michael David M.D. J.D., Executive Vice President - Pre-Clinical Development, Chief Strategy Officer
  • Sharon Collins Presnell Ph.D., Chief Scientific Officer
  • Jennifer Kinsbruner Bush J.D., Compliance Officer, General Counsel, Corporate Secretary
  • Paul Gallant, General Manager
  • Richard Maroun, Director
  • Robert F. Baltera Jr., Lead Independent Director
  • James T. Glover, Independent Director
  • Richard A. Heyman Ph.D., Independent Director
  • Tamar D. Howson, Independent Director

How do I buy Organovo Holdings stock?

Shares of Organovo Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Organovo Holdings' stock price today?

One share of Organovo Holdings stock can currently be purchased for approximately $1.52.

MarketBeat Community Rating for Organovo Holdings (NASDAQ ONVO)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  133
MarketBeat's community ratings are surveys of what our community members think about Organovo Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Organovo Holdings (NASDAQ:ONVO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.94 (356.41% upside)
Consensus Price Target History for Organovo Holdings (NASDAQ:ONVO)
Price Target History for Organovo Holdings (NASDAQ:ONVO)
Analysts' Ratings History for Organovo Holdings (NASDAQ:ONVO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/26/2017Jefferies Group LLCReiterated RatingBuy$4.00HighView Rating Details
6/9/2017Evercore ISIReiterated RatingOutperform$4.00 -> $3.75LowView Rating Details
1/25/2017Raymond James Financial, Inc.Initiated CoverageOutperform$5.00N/AView Rating Details
12/15/2016BTIG ResearchInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Organovo Holdings (NASDAQ:ONVO)
Earnings by Quarter for Organovo Holdings (NASDAQ:ONVO)
Earnings History by Quarter for Organovo Holdings (NASDAQ ONVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017($0.10)N/AView Earnings Details
8/9/2017Q1 2018($0.10)($0.10)$0.92 million$0.99 millionViewListenView Earnings Details
6/7/2017Q4 2017($0.11)($0.10)$0.76 million$0.80 millionViewListenView Earnings Details
2/9/2017Q3 2017($0.10)($0.09)$1.40 million$1.15 millionViewListenView Earnings Details
11/3/2016Q217($0.11)($0.10)$0.50 million$1.38 millionViewListenView Earnings Details
8/4/2016Q1($0.10)($0.09)$0.30 million$0.89 millionViewListenView Earnings Details
6/9/2016Q4($0.11)($0.09)$0.10 million$0.55 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Organovo Holdings (NASDAQ:ONVO)
2018 EPS Consensus Estimate: ($0.10)
2019 EPS Consensus Estimate: ($0.32)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181($0.10)($0.10)($0.10)
Q1 20191($0.09)($0.09)($0.09)
Q2 20191($0.09)($0.09)($0.09)
Q3 20191($0.07)($0.07)($0.07)
Q4 20191($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)


Dividend History for Organovo Holdings (NASDAQ:ONVO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Organovo Holdings (NASDAQ:ONVO)
Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 23.94%
Insider Trades by Quarter for Organovo Holdings (NASDAQ:ONVO)
Institutional Ownership by Quarter for Organovo Holdings (NASDAQ:ONVO)
Insider Trades by Quarter for Organovo Holdings (NASDAQ:ONVO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Keith MurphyCEOSell25,000$3.68$92,000.00View SEC Filing  
1/24/2017Keith MurphyCEOSell25,000$3.51$87,750.00View SEC Filing  
12/14/2016Keith MurphyCEOSell50,000$3.72$186,000.00View SEC Filing  
8/5/2016Eric DavidEVPSell20,000$4.55$91,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Organovo Holdings (NASDAQ:ONVO)
Latest Headlines for Organovo Holdings (NASDAQ:ONVO)
DateHeadline logoOrganovo Holdings, Inc. (ONVO) Stock Rating Upgraded by Zacks Investment Research - October 15 at 11:32 PM logoCritical Review: Organovo Holdings (ONVO) & Its Rivals - October 13 at 2:20 PM logoETFs with exposure to Organovo Holdings, Inc. : October 9, 2017 - October 9 at 8:48 PM logoQ3 2018 EPS Estimates for Organovo Holdings, Inc. Decreased by Analyst (ONVO) - October 9 at 5:56 AM logoOrganovo Holdings, Inc. (ONVO) Given Average Rating of "Hold" by Brokerages - October 8 at 9:00 AM logoOrganovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017 - October 6 at 9:11 AM logoOrganovo to cut 13% of workforce, announces preliminary revenues - Seeking Alpha - October 5 at 1:56 PM logoOrganovo Holdings, Inc. (ONVO) Receives "Buy" Rating from Jefferies Group LLC - September 26 at 8:56 PM logoThe Competitive Case For Organovo Holdings - Seeking Alpha - September 22 at 7:31 AM logoJefferies Group LLC Reiterates "Buy" Rating for Organovo Holdings, Inc. (ONVO) - September 14 at 7:16 PM logoOrganovo Holdings, Inc. (ONVO) Given Average Recommendation of "Hold" by Analysts - September 13 at 9:34 AM logoBRIEF-Organovo says Keith Murphy submitted resignation as chairman of board‍ - August 29 at 6:23 AM logoGlobal 3D Bioprinting Market Outlook to 2022 - Focus on Technology, Application and Materials - Research and Markets - August 26 at 8:01 AM logoOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease - Nasdaq - August 23 at 9:49 AM logoOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease - August 23 at 9:49 AM logoOrganovo Holdings, Inc. (ONVO) Receives Consensus Rating of "Buy" from Analysts - August 19 at 9:02 AM logoQ3 2018 Earnings Forecast for Organovo Holdings, Inc. (NASDAQ:ONVO) Issued By Jefferies Group - August 14 at 7:54 AM logoETFs with exposure to Organovo Holdings, Inc. : August 11, 2017 - August 12 at 6:36 AM logoOrganovo Holdings, Inc. (ONVO) Announces Earnings Results, Hits Estimates - August 11 at 9:58 PM logoOrganovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters - August 11 at 7:16 AM logoInvestor Network: Organovo Holdings, Inc. to Host Earnings Call - August 10 at 6:29 AM logoOrganovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook - August 10 at 6:29 AM logoEdited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMT - August 10 at 6:29 AM logoOrganovo reports 1Q loss - August 10 at 6:29 AM logoOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease - August 1 at 5:34 AM logoOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease - - August 1 at 12:31 AM logoOrganovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease - August 1 at 12:31 AM logoETFs with exposure to Organovo Holdings, Inc. : July 31, 2017 - August 1 at 12:31 AM logoOrganovo Holdings, Inc. (ONVO) Short Interest Down 7.2% in July - July 28 at 1:24 AM logoOrganovo Holdings, Inc. (NASDAQ:ONVO) Rating Reiterated by Jefferies Group LLC - July 27 at 5:55 PM logo$880,000.00 in Sales Expected for Organovo Holdings, Inc. (NASDAQ:ONVO) This Quarter - July 20 at 11:44 AM logoOrganovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results - July 19 at 12:55 AM logoHow Risky Is Organovo Holdings, Inc.? - July 18 at 4:13 PM logoOrganovo - Going The Right Direction - Seeking Alpha - July 15 at 7:12 AM logoETFs with exposure to Organovo Holdings, Inc. : July 13, 2017 - July 14 at 7:09 AM logoHere's Why Organovo Holdings Inc Fell 10.5% in June - July 11 at 6:24 AM logoETFs with exposure to Organovo Holdings, Inc. : July 3, 2017 - July 4 at 2:59 AM logo3 Reasons Organovo Holdings, Inc. Stock Could Fall Even More - June 22 at 4:32 PM logoOrganovo to Present at Jefferies Healthcare Conference - GlobeNewswire (press release) - June 5 at 7:39 PM logoResearch Reports Initiation on Medical Labs Stocks -- Organovo, DexCom, Quest ... - May 9 at 11:17 AM logoClearside Biomedical, Inc. Announces Completion Of Patient Enrollment In Phase 1/2 Open Label Clinical Trial Of CLS-TA In Diabetic Macular Edema - April 20 at 9:07 AM logoOrganovo Holdings CEO Leaves: Should Investors Be Worried? - Motley Fool - April 14 at 8:03 AM logoWhat's Next for Organovo Holdings Inc.? - Motley Fool - April 12 at 7:59 PM logo2 inmates charged with killing 4 in South Carolina prison - USA TODAY - April 8 at 6:17 PM logoTrump Shifts Course on Egypt, Praising Its Authoritarian Leader - New York Times - April 3 at 6:24 PM logoChina Learns How to Get Trump's Ear: Through Jared Kushner - New York Times - April 2 at 10:53 AM logoSenate panel to vote on Supreme Court nominee Neil Gorsuch - USA TODAY - April 2 at 10:53 AM logoMichael Flynn left Russian speaking fees off initial financial disclosures - CNN - April 2 at 10:53 AM logoPart of I-85 collapses in Atlanta after massive fire - March 31 at 12:21 AM logoWhite House adviser Jared Kushner to appear before Senate Intelligence Committee - March 27 at 9:55 AM



Organovo Holdings (ONVO) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.